Idelalisib or placebo in combination with bendamustine and rituximab in patients with relapsed or refractory chronic lymphocytic leukaemia: interim results from a phase 3, randomised, double-blind, placebo-controlled trial
dc.contributor.author | Zelenetz, Andrew D. | |
dc.contributor.author | Barrientos, Jacqueline C. | |
dc.contributor.author | Brown, Jennifer R. | |
dc.contributor.author | Coiffier, Bertrand | |
dc.contributor.author | Delgado, Julio | |
dc.contributor.author | Egyed, Miklós | |
dc.contributor.author | Ghia, Paolo | |
dc.contributor.author | Illés, Árpád | |
dc.contributor.author | Jurczak, Wojciech | |
dc.contributor.author | Murlton, Paula | |
dc.contributor.author | Montillo, Marco | |
dc.contributor.author | Morschhauser, Franck | |
dc.contributor.author | Pristupa, Alexander S. | |
dc.contributor.author | Robak, Tadeusz | |
dc.contributor.author | Sharman, Jeff P. | |
dc.contributor.author | Simpson, David | |
dc.contributor.author | Smolej, Lukás | |
dc.contributor.author | Tausch, Eugen | |
dc.contributor.author | Adewoye, Adeboye H. | |
dc.contributor.author | Dreiling, Lyndah K. | |
dc.contributor.author | Kim, Yeonhee | |
dc.contributor.author | Stilgenbaur, Stephan | |
dc.contributor.author | Hillmen, Peter | |
dc.date.accessioned | 2017-08-02T11:15:19Z | |
dc.date.available | 2017-08-02T11:15:19Z | |
dc.date.issued | 2017 | |
dc.date.oa | 2018-03-29 | |
dc.date.pasync | 2018-05-17T00:30:23Z | |
dc.date.updated | 2018-05-17T00:30:23Z | |
dc.description.corrector | KA | |
dc.identifier.citation | Lancet Oncology. - 18 (2017), p. 297-311. -Lancet Oncol. - 1470-2045 | |
dc.identifier.issn | 1470-2045 | |
dc.identifier.opac | http://webpac.lib.unideb.hu:8082/ebib/CorvinaWeb?action=cclfind&resultview=long&ccltext=idno+BIBFORM070024 | |
dc.identifier.original | https://www.sciencedirect.com/science/article/pii/S1470204516306714?via%3Dihub | |
dc.identifier.uri | http://hdl.handle.net/2437/242826 | |
dc.language | eng | |
dc.rights.access | open access pre-print és post-print | |
dc.rights.owner | Elsevier | |
dc.subject.mab | Orvostudományok | |
dc.subject.mab | Klinikai orvostudományok | |
dc.title | Idelalisib or placebo in combination with bendamustine and rituximab in patients with relapsed or refractory chronic lymphocytic leukaemia: interim results from a phase 3, randomised, double-blind, placebo-controlled trial | |
dc.type | folyóiratcikk |